The 5th International Conference on Gastroenterology and Hepatology, scheduled for May 13–14, 2027, in Rome, Italy, is a premier international scientific event dedicated to advancing research, clinical practice, and innovation in digestive and liver health. The conference will bring together leading gastroenterologists, hepatologists, physicians, surgeons, researchers, academicians, healthcare professionals, industry experts, and students from around the world to discuss the latest breakthroughs and emerging trends in the field.
Under the theme, "Advancing Digestive and Liver Health Through Innovation, Research, and Clinical Excellence," the conference provides a dynamic platform for presenting cutting-edge research, sharing clinical experiences, and fostering interdisciplinary collaboration. The scientific program will feature keynote lectures, plenary sessions, oral and poster presentations, workshops, panel discussions, and networking opportunities that encourage the exchange of knowledge and the development of innovative solutions to improve patient care.
Why Attend?
Participating in the 5th International Conference on Gastroenterology and Hepatology provides an excellent opportunity to stay at the forefront of digestive and liver healthcare through scientific exchange, professional networking, and clinical innovation.
Target Audience
The conference welcomes professionals and researchers from academia, healthcare, research organizations, and industry, including:
Scientific Sessions & Tracks
The 5th International Conference on Gastroenterology and Hepatology will feature comprehensive scientific sessions covering the latest advances in digestive and liver health, clinical practice, translational research, and emerging technologies.
Track 1: Gastrointestinal Disorders
This session focuses on the diagnosis, prevention, and management of common and complex gastrointestinal diseases. Discussions will include upper and lower GI disorders, evidence-based treatment strategies, and innovations in patient care.
Track 2: Hepatology and Liver Diseases
This track highlights advances in liver disease research and clinical management, including viral hepatitis, fatty liver disease, cirrhosis, and liver failure.
Hepatitis | Fatty Liver Disease | Cirrhosis | Liver Fibrosis | Liver Failure | Hepatic Complications
Track 3: Gastrointestinal Endoscopy
This session covers diagnostic and therapeutic endoscopic procedures, emerging endoscopic technologies, and minimally invasive interventions.
Upper GI Endoscopy | Colonoscopy | ERCP | EUS | Therapeutic Endoscopy | Capsule Endoscopy
Track 4: Liver Transplantation
This track focuses on pre-transplant evaluation, donor selection, immunosuppression, post-transplant complications, and long-term outcomes.
Track 5: Gastrointestinal Oncology
This session explores the prevention, early detection, molecular profiling, and treatment of gastrointestinal cancers.
Track 6: Inflammatory Bowel Disease (IBD)
This track addresses pathogenesis, biomarkers, biologic therapies, disease monitoring, and personalized approaches for Crohn’s disease and ulcerative colitis.
Crohn’s Disease | Ulcerative Colitis | Biologic Therapy | IBD Biomarkers | Mucosal Healing
Track 7: Pancreatic Diseases
This session focuses on inflammatory and neoplastic pancreatic disorders, advanced imaging, and therapeutic strategies.
Track 8: Esophageal Disorders
This track covers reflux disease, motility disorders, Barrett’s esophagus, and esophageal malignancies.
GERD | Barrett’s Esophagus | Achalasia | Esophageal Motility | Esophageal Cancer
Track 9: Colorectal Diseases
This session discusses colorectal neoplasia, inflammatory and functional colorectal disorders, and surgical innovations.
Colorectal Polyps | Diverticular Disease | Colorectal Screening | Hemorrhoids | Colorectal Surgery
Track 10: Microbiome and Gut Health
This track explores gut microbiota, host-microbe interactions, microbiome-based therapies, and their role in digestive and systemic diseases.
Gut Microbiota | Dysbiosis | Probiotics | Prebiotics | Fecal Microbiota Transplantation
Track 11: Digestive Nutrition and Clinical Dietetics
This session focuses on nutritional assessment and dietary interventions in gastrointestinal and liver disorders.
Track 12: Pediatric Gastroenterology
This track highlights digestive and liver diseases in infants, children, and adolescents, including congenital and inflammatory disorders.
Track 13: Artificial Intelligence in Gastroenterology
This session examines AI-assisted diagnosis, image analysis, predictive modeling, and digital health applications.
Track 14: Advanced Imaging and Diagnostics
This track covers state-of-the-art imaging modalities and molecular diagnostics for gastrointestinal and liver diseases.
CT Imaging | MRI | Elastography | Molecular Diagnostics | Biomarkers | Advanced Pathology
Track 15: Functional Gastrointestinal Disorders
This session addresses disorders of gut-brain interaction, including IBS and functional dyspepsia.
Track 16: Hepatobiliary and Biliary Diseases
This track focuses on gallbladder and biliary tract disorders, cholestatic liver disease, and interventional management.
Gallstones | Cholangitis | Biliary Strictures | Cholestatic Disease | Biliary Interventions
Track 17: Gastrointestinal Surgery and Minimally Invasive Procedures
This session explores laparoscopic, robotic, and endoscopic surgical techniques for digestive diseases.
Track 18: Precision Medicine and Translational Research
This track highlights genomics, biomarkers, targeted therapies, and translational approaches to personalized digestive and liver care.
Track 19: Emerging Therapeutics and Clinical Trials
This session covers novel pharmacologic agents, biologics, regenerative medicine, and ongoing clinical research.
Track 20: Global Perspectives in Gastroenterology and Hepatology
This track examines international guidelines, public health strategies, healthcare delivery, and future challenges in digestive and liver health.
The 5th International Conference on Gastroenterology and Hepatology offers exceptional opportunities for scientific learning, professional development, networking, and global collaboration. Participants will gain valuable insights into the latest research, clinical innovations, and technological advancements in digestive and liver healthcare.
Market Analysis Report
The global Gastroenterology and Hepatology market is projected to reach approximately USD 65–75 billion by 2027, growing at a CAGR of 6–8%. Market growth is driven by the rising prevalence of gastrointestinal disorders, liver diseases, colorectal cancer, inflammatory bowel disease (IBD), obesity, and metabolic liver disorders, along with increasing demand for advanced diagnostics and minimally invasive procedures. North America continues to lead the market due to strong healthcare infrastructure, while the Asia-Pacific region is expected to witness the fastest growth owing to expanding healthcare investments and increasing disease awareness. Emerging technologies such as artificial intelligence, precision medicine, advanced endoscopy, molecular diagnostics, and microbiome-based therapies are transforming digestive and liver healthcare, creating significant opportunities for research, innovation, and global collaboration.